Acrux is a pharmaceutical company dedicated to developing and commercialising generic and specialty topical pharmaceuticals. Incorporated in 1998 and using in house facilities and capabilities, Acrux has successfully developed and commercialised, through licensees, a number of pharmaceutical products in the US, Europe and other markets.
Commonly accessed information
Partnering With Us
We are proud to partner with highly experienced and professional global pharmaceutical companies who are passionate and focused on providing products which benefit to patients.
Our marketing partners include Perrigo, Elanco and Gedeon Richter.
Learn more about our partners by clicking here.
Product Pipeline
Development of our product pipeline is our primary focus.
We believe that investment in research and development will create future value for our business and our shareholders. Our scientists use our own laboratory to research new formulations and new therapies.
Our pipeline includes a broad range of products in varying stages of development.
Access our Product Pipeline by clicking here.
Announcements
As a public company, all material announcements are released on the ASX. In addition, we also provide access to this information via our website. Click here to access ASX announcements.
Annual Report
Our Annual Report is available to download electronically.
Access our Annual Report by clicking here.